Literature DB >> 11079152

Thrombosis in cancer patients.

H F Hillen1.   

Abstract

VTE is a common complication in cancer patients and may even be the first sign of malignancy. Cancer induces activation of the blood coagulation in most cancer patients. Tissue factor and cancer procoagulant are expressed on tumour cells, leading to activation of clotting factors VII and X. Cytokines released from tumour cells activate coagulant activity on monocytes, thrombocytes, and endothelial cells. This process of activated clotting enhances clinical VTE. Low-molecular weight heparins are effective and safe for the prevention and treatment of VTE in cancer patients. Activated coagulation supports tumour growth and angiogenesis. This concept may offer interesting new strategies for the treatment of cancer [28].

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 11079152     DOI： 10.1093/annonc/11.suppl_3.273

Source DB:  PubMed          Journal:  Ann Oncol        ISSN： 0923-7534            Impact factor:   32.976


  10 in total

1.  Pancreatic cancer: A model cancer for the study of the therapeutic effects of anticoagulants.

Authors:  Anthony Maraveyas
Journal:  World J Gastrointest Oncol       Date:  2009-10-15

2.  Inferior vena cava filtration in the management of venous thromboembolism: filtering the data.

Authors:  Christopher Molvar
Journal:  Semin Intervent Radiol       Date:  2012-09       Impact factor: 1.513

3.  Romiplostim for management of chemotherapy-induced thrombocytopenia.

Authors:  R Parameswaran; M Lunning; S Mantha; S Devlin; A Hamilton; G Schwartz; G Soff
Journal:  Support Care Cancer       Date:  2014-01-12       Impact factor: 3.603

Review 4.  Much More than Trousseau Syndrome. The Broad Spectrum of the Pancreatic Paraneoplastic Syndromes.

Authors:  Attila Zalatnai; Eszter Perjési; Eszter Galambos
Journal:  Pathol Oncol Res       Date:  2017-02-03       Impact factor: 3.201

Review 5.  Pathophysiology and management of thrombosis in cancer: 150 years of progress.

Authors:  Gerald A Soff
Journal:  J Thromb Thrombolysis       Date:  2013-04       Impact factor: 2.300

Review 6.  Current advances in understanding and managing secondary brain metastasis.

Authors:  Radhika Dasararaju; Amitkumar Mehta
Journal:  CNS Oncol       Date:  2013-01

7.  Comparison of Enoxaparin and Warfarin for Secondary Prevention of Cancer-Associated Stroke.

Authors:  Hyemin Jang; Jung Jae Lee; Mi Ji Lee; Sookyung Ryoo; Chang Hyo Yoon; Gyeong-Moon Kim; Chin-Sang Chung; Kwang Ho Lee; Oh Young Bang; Suk Jae Kim
Journal:  J Oncol       Date:  2015-05-07       Impact factor: 4.375

8.  Serum fibrinogen levels are positively correlated with advanced tumor stage and poor survival in patients with gastric cancer undergoing gastrectomy: a large cohort retrospective study.

Authors:  Xuefeng Yu; Fulan Hu; Qiang Yao; Chunfeng Li; Hongfeng Zhang; Yingwei Xue
Journal:  BMC Cancer       Date:  2016-07-14       Impact factor: 4.430

Review 9.  Cancer-Associated Thrombosis: A New Light on an Old Story.

Authors:  Sidrah Shah; Afroditi Karathanasi; Antonios Revythis; Evangelia Ioannidou; Stergios Boussios
Journal:  Diseases       Date:  2021-05-04

10.  A panel of glycoproteins as candidate biomarkers for early diagnosis and treatment evaluation of B-cell acute lymphoblastic leukemia.

Authors:  Marcio de Souza Cavalcante; José Camilo Torres-Romero; Marina Duarte Pinto Lobo; Frederico Bruno Mendes Batista Moreno; Leonardo Primo Bezerra; Diego Silva Lima; Jesamar Correia Matos; Renato de Azevedo Moreira; Ana Cristina de Oliveira Monteiro-Moreira
Journal:  Biomark Res       Date:  2016-01-27
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.